X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.businesswire.com/news/home/20230209005245/en/Basking-Biosciences-Presents-Positive-Clinical-Results-from-Safety-and-Dose-Escalation-Study-for-First-Reversible-Thrombolytic-Agent-at-ISC-2023